MX3277E - Procedimiento para la preparacion de derivados de eritromicina - Google Patents

Procedimiento para la preparacion de derivados de eritromicina

Info

Publication number
MX3277E
MX3277E MX000145U MX14576U MX3277E MX 3277 E MX3277 E MX 3277E MX 000145 U MX000145 U MX 000145U MX 14576 U MX14576 U MX 14576U MX 3277 E MX3277 E MX 3277E
Authority
MX
Mexico
Prior art keywords
group
carbon atoms
moiety
alcohol
general formula
Prior art date
Application number
MX000145U
Other languages
English (en)
Spanish (es)
Inventor
Wolfgang Reuter
Roland Maier
Eberhard Woitun
Bernd Wetzel
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX3277(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of MX3277E publication Critical patent/MX3277E/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX000145U 1975-04-07 1976-04-06 Procedimiento para la preparacion de derivados de eritromicina MX3277E (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
MX3277E true MX3277E (es) 1980-08-15

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX000145U MX3277E (es) 1975-04-07 1976-04-06 Procedimiento para la preparacion de derivados de eritromicina

Country Status (29)

Country Link
US (1) US4048306A (OSRAM)
JP (1) JPS51128991A (OSRAM)
AT (1) AT342770B (OSRAM)
AU (1) AU498418B2 (OSRAM)
BG (1) BG27380A3 (OSRAM)
CA (1) CA1060005A (OSRAM)
CH (2) CH621800A5 (OSRAM)
CS (1) CS196304B2 (OSRAM)
DD (1) DD125218A5 (OSRAM)
DK (1) DK138656C (OSRAM)
ES (2) ES446737A1 (OSRAM)
FI (1) FI63244C (OSRAM)
FR (1) FR2306703A1 (OSRAM)
GB (1) GB1520963A (OSRAM)
GR (1) GR60374B (OSRAM)
HU (1) HU175186B (OSRAM)
IE (1) IE43598B1 (OSRAM)
IL (1) IL49359A (OSRAM)
LU (2) LU74702A1 (OSRAM)
MX (1) MX3277E (OSRAM)
NL (1) NL180107C (OSRAM)
NO (1) NO141411C (OSRAM)
NZ (1) NZ180529A (OSRAM)
PL (1) PL101880B1 (OSRAM)
PT (1) PT64977B (OSRAM)
RO (1) RO68441B (OSRAM)
SE (1) SE425566B (OSRAM)
SU (1) SU682134A3 (OSRAM)
YU (1) YU87676A (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847242A (en) 1985-03-12 1989-07-11 Beecham Group P.L.C. 11-ether derivatives of erythromycins
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
KR0166096B1 (ko) * 1990-11-28 1999-01-15 우에하라 아키라 6-0-메틸에리쓰로마이신 a 유도체
ZA922776B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical compounds
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
MY113261A (en) * 1991-09-30 2002-01-31 Lilly Co Eli One step process for production of dirithromycin.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
DK138656C (da) 1979-04-02
NO141411B (no) 1979-11-26
FI63244B (fi) 1983-01-31
RO68441A (ro) 1983-04-29
HU175186B (hu) 1980-05-28
SE425566B (sv) 1982-10-11
ES446737A1 (es) 1977-10-16
PT64977B (de) 1978-04-03
FR2306703A1 (fr) 1976-11-05
ES456567A1 (es) 1978-03-01
NO141411C (no) 1980-03-05
IE43598L (en) 1976-10-07
SU682134A3 (ru) 1979-08-25
ATA149976A (de) 1977-08-15
NL180107B (nl) 1986-08-01
IL49359A0 (en) 1976-06-30
LU88563I2 (fr) 1995-03-21
CH624413A5 (OSRAM) 1981-07-31
PT64977A (de) 1976-05-01
AU498418B2 (en) 1979-03-15
NL180107C (nl) 1987-01-02
CS196304B2 (en) 1980-03-31
DK138656B (da) 1978-10-09
AU1272276A (en) 1977-10-13
NZ180529A (en) 1978-09-20
LU74702A1 (OSRAM) 1977-06-03
RO68441B (ro) 1983-04-30
FI63244C (fi) 1983-05-10
NO761172L (OSRAM) 1976-10-08
DK145276A (da) 1976-10-08
JPS51128991A (en) 1976-11-10
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
FR2306703B1 (OSRAM) 1979-10-12
YU87676A (en) 1982-08-31
BG27380A3 (bg) 1979-10-12
IL49359A (en) 1979-07-25
US4048306A (en) 1977-09-13
CH621800A5 (OSRAM) 1981-02-27
FI760845A7 (OSRAM) 1976-10-08
GB1520963A (en) 1978-08-09
JPS62158B2 (OSRAM) 1987-01-06
AT342770B (de) 1978-04-25
CA1060005A (en) 1979-08-07
DD125218A5 (de) 1977-04-06
PL101880B1 (pl) 1979-02-28
SE7604052L (sv) 1976-10-08
NL7603569A (nl) 1976-10-11

Similar Documents

Publication Publication Date Title
MX3277E (es) Procedimiento para la preparacion de derivados de eritromicina
JPS51115478A (en) Piperidine derivatives acid addidion salt and optical isomer
ES462062A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES302622A1 (es) Procedimiento para la preparacion de derivados heterociclicos.
AR023308A1 (es) Uso de dihidropirimidinas para la preparacion de un medicamento, dihidropirimidinas, procedimiento para su produccion y preparados farmaceuticos que loscontienen.
CO5690585A2 (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
SE422824B (sv) Anordning vid forbrenningsmotorer
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
SE7604593L (sv) Anordning vid en overladdad forbrenningmotor
SE422839B (sv) Anordning for forbrenning av foreddade brenslen
DK219488A (da) Benzo- og thieno-3,4-dihydropyridinderivater, deres fremstilling og laegemidler indeholdende forbindelserne
IT1067334B (it) Derivati piperidinici per denti frici
ES450943A1 (es) Procedimiento para la preparacion de amidas de acido 3-piri-dil-oxi-alcancarboxilico.
ES476241A1 (es) Procedimiento para la preparacion de derivados de tetraciclonomano.
MX173423B (es) DERIVADOS DE 1-ARILSULFINIL-2-PIRROLIDINONA Y P ROCEDIMIENTO PARA SU PREPARACION R1, donde R1, en cualquier posición sobre el núcleR3 donde R2 y R3, identicos o difernetes represent
ES452648A1 (es) Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
ES407519A1 (es) Procedimiento para la preparacion de nuevas 2-(5-nitro-2- furil)-tieno (2,3-d) pirimidas.
ES444036A1 (es) Procedimiento de preparacion de la (tienil-2)-2-etilamina y sus derivados.
ES484246A1 (es) Procedimiento de preparacion de nuevos derivados de ortoclo-robenzoil-2-cloro-4 glicilanilidas
ES383467A1 (es) Procedimiento para la preparacion de derivados de pirrol.
SE392831B (sv) Anordning vid inmatningsbenkar for kantverk
ES426329A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,3,4-tetrahidroisoquinoleina.
ES386460A1 (es) Un procedimiento para la preparacion de acidos indolaceti- cos y derivados.
ES280829A1 (es) Procedimiento de preparación de derivados de la amino-4 quinoleína
ES322947A1 (es) Procedimiento para obtener un material de diazotipia con capa fotosensible de uno o dos componentes.